Research and development

Lundbeck’s research and development (R&D) efforts are dedicated to creating new and innovative pharmaceuticals for the treatment of psychiatric and neurological disorders. Through investment and perseverance, we strive to create the very best treatments for patients.

Research is our foundation

Research is our foundation
Lundbeck is the only fully-integrated pharmaceutical company in the world, solely devoted to the treatment of psychiatric and neurological disorders. We dedicate our entire R&D efforts to develop innovative drugs for treatment of a number of psychiatric and neurological disorders. Our R&D projects focus on:

  • Alzheimer’s disease
  • Depression
  • Parkinson’s disease
  • Schizophrenia

Read more about our disease areas.

Underlying disease biology
Lundbeck’s R&D strategy is aimed at enabling the discovery and development of new pharmaceuticals targeting the underlying mechanisms of brain diseases. This approach allows us to treat the symptoms more effectively and potentially also to alter the course of the diseases. The strategy requires comprehensive research into the brain and the biology and mechanisms of brain diseases, as well as improved understanding of research targets and clinical outcomes.

Strategic partnerships
Essential to the R&D strategy is for Lundbeck to maintain strong internal R&D capabilities in order to establish optimal networks and partnerships. We will continue to build external alliances to supplement our internal capabilities, taking advantage of the increased opportunities provided by innovative technologies. 

Future platform
Our R&D strategy will provide a future platform from which Lundbeck can discover and develop drugs with clearly documented effects on biologically defined patient groups. It is expected that society’s demand for these new types of drugs will increase. 

Go to our pipeline

Our R&D organization
As a medium-sized pharmaceutical company, we share common values in the way we work worldwide and keep a clear focus in our R&D strategy. Research at Lundbeck is based on the efforts of our multi-disciplinary, empowered project teams, our in-house expertise in the brain disease area and our state-of-the-art technologies. We work in new, well-equipped laboratories. In each project team, we integrate our advanced knowledge in R&D disciplines with expertise in clinical practices and therapeutic needs.

Global presence
Our R&D organization is international and consists of more than 800 dedicated R&D staff. The research organization is located in Copenhagen, Denmark. Development headquarters are also situated in Copenhagen, Denmark with clinical research and regulatory personnel spread worldwide.

Respect for the individual
In Lundbeck, we work together as individuals towards common goals. We seek to constantly develop and improve our scientific and personal skills and qualifications. This allows us to promote career opportunities for the individual, as well as maintain and develop our competencies as an organization. Publication of our scientific results is a natural part of our participation as active members in the international scientific community.

Go to a list of our publications

Development of a new pharmaceutical product

No. of molecules / No. of patients

Read more about the development process

Fast facts about Lundbeck

Corporate headquarter

Lundbeck is a global pharmaceutical company working within brain diseases.

Read more
Cookie Policy
You have chosen to leave Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on